We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
-1.8%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$14.9B
AUM Growth
-$469M
Cap. Flow
+$265M
Cap. Flow %
1.78%
Top 10 Hldgs %
22.66%
Holding
1,625
New
16
Increased
382
Reduced
280
Closed
60

Sector Composition

Rank Sector Weight
1 Technology 25.24%
2 Healthcare 22.04%
3 Financials 11.22%
4 Consumer Discretionary 10.64%
5 Industrials 10.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
G icon
576
Genpact
G
$5.78B
$1.37M 0.01%
31,300
AFG icon
577
American Financial Group
AFG
$12.1B
$1.36M 0.01%
11,100
CRL icon
578
Charles River Laboratories
CRL
$13.4B
$1.36M 0.01%
6,937
TRU icon
579
TransUnion
TRU
$15.5B
$1.36M 0.01%
22,917
-275
-1% -$21.1K
SWAV
580
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$1.36M 0.01%
4,900
-900
-16% -$229K
SBNY
581
DELISTED
Signature Bank
SBNY
$1.36M 0.01%
9,000
ZION icon
582
Zions Bancorporation
ZION
$10.5B
$1.34M 0.01%
26,400
+700
+3% +$38.3K
PLTR icon
583
Palantir
PLTR
$430B
$1.34M 0.01%
164,300
-13,200
-7% -$117K
DPZ icon
584
Domino's
DPZ
$11.6B
$1.33M 0.01%
4,300
+192
+5% +$72.9K
ARES icon
585
Ares Management
ARES
$33.7B
$1.32M 0.01%
21,300
WBS icon
586
Webster Financial
WBS
$12.8B
$1.31M 0.01%
29,093
QGEN icon
587
Qiagen
QGEN
$8.93B
$1.31M 0.01%
29,989
BHVN
588
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$1.3M 0.01%
8,600
-56,000
-87% -$8.3M
RGA icon
589
Reinsurance Group of America
RGA
$16.4B
$1.28M 0.01%
10,200
SRPT icon
590
Sarepta Therapeutics
SRPT
$1.95B
$1.28M 0.01%
11,602
BIO icon
591
Bio-Rad Laboratories Class A
BIO
$9.66B
$1.28M 0.01%
3,072
AIZ icon
592
Assurant
AIZ
$13.9B
$1.28M 0.01%
8,800
CUBE icon
593
CubeSmart
CUBE
$9.4B
$1.26M 0.01%
31,534
REXR icon
594
Rexford Industrial Realty
REXR
$8.12B
$1.26M 0.01%
24,202
WSM icon
595
Williams-Sonoma
WSM
$28.5B
$1.26M 0.01%
21,320
CFR icon
596
Cullen/Frost Bankers
CFR
$10.5B
$1.25M 0.01%
9,416
WB icon
597
Weibo
WB
$1.88B
$1.24M 0.01%
72,660
+4,000
+6% +$77.3K
UTHR icon
598
United Therapeutics
UTHR
$21.5B
$1.24M 0.01%
5,900
DECK icon
599
Deckers Outdoor
DECK
$12.7B
$1.23M 0.01%
23,664
BURL icon
600
Burlington
BURL
$22.4B
$1.23M 0.01%
11,000

Similar funds

Handelsbanken Fonder's Q3 2022 Portfolio in Review

As of Q3 2022, Handelsbanken Fonder held 1,625 positions worth $14.9B, down 3% from $15.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q3 2022: portfolio turnover was 4.7%. Handelsbanken Fonder opened 16 new positions and exited 60, leaving the 1,625-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

  • Handelsbanken Fonder's largest Q3 2022 buy was Aaon: 11,124 shares worth $400K.
  • Handelsbanken Fonder added most to Apple in Q3 2022, an estimated $34.1M increase.
  • Handelsbanken Fonder's biggest Q3 2022 reduction was Livent Corporation, cutting an estimated $22.1M.
  • Handelsbanken Fonder fully exited Bandwidth Inc in Q3 2022, selling an estimated $5.32M.
  • Handelsbanken Fonder's ten largest holdings make up 23% of its $14.9B portfolio in Q3 2022.
  • Handelsbanken Fonder opened 16 new positions and closed 60 in Q3 2022.
  • Handelsbanken Fonder's portfolio value fell 3% quarter-over-quarter to $14.9B.

Based on Handelsbanken Fonder's 13F filing for Q3 2022, filed 27 Oct 2022.